Yagi M - Search Results

1

Gene-based therapy for inner ear disease.

Kawamoto K, Kanzaki S, Yagi M, Stöver T, Prieskorn DM, Dolan DF, Miller JM, Raphael Y. Kawamoto K, et al. Among authors: yagi m. Noise Health. 2001;3(11):37-47. Noise Health. 2001. PMID: 12689447

2

From gene identification to gene therapy.

Kanzaki S, Kawamoto K, Oh SH, Stöver T, Suzuki M, Ishimoto S, Yagi M, Miller JM, Lomax MI, Raphael Y. Kanzaki S, et al. Among authors: yagi m. Audiol Neurootol. 2002 May-Jun;7(3):161-4. doi: 10.1159/000058303. Audiol Neurootol. 2002. PMID: 12053138

3

Hearing and hair cells are protected by adenoviral gene therapy with TGF-beta1 and GDNF.

Kawamoto K, Yagi M, Stöver T, Kanzaki S, Raphael Y. Kawamoto K, et al. Among authors: yagi m. Mol Ther. 2003 Apr;7(4):484-92. doi: 10.1016/s1525-0016(03)00058-3. Mol Ther. 2003. PMID: 12727111 Free article.

4

Chronic excitotoxicity in the guinea pig cochlea induces temporary functional deficits without disrupting otoacoustic emissions.

Le Prell CG, Yagi M, Kawamoto K, Beyer LA, Atkin G, Raphael Y, Dolan DF, Bledsoe SC Jr, Moody DB. Le Prell CG, et al. Among authors: yagi m. J Acoust Soc Am. 2004 Aug;116(2):1044-56. doi: 10.1121/1.1772395. J Acoust Soc Am. 2004. PMID: 15376671

5

Inner ear transgene expression after adenoviral vector inoculation in the endolymphatic sac.

Yamasoba T, Yagi M, Roessler BJ, Miller JM, Raphael Y. Yamasoba T, et al. Among authors: yagi m. Hum Gene Ther. 1999 Mar 20;10(5):769-74. doi: 10.1089/10430349950018526. Hum Gene Ther. 1999. PMID: 10210144

6

Cochlear gene transfer: round window versus cochleostomy inoculation.

Stöver T, Yagi M, Raphael Y. Stöver T, et al. Among authors: yagi m. Hear Res. 1999 Oct;136(1-2):124-30. doi: 10.1016/s0378-5955(99)00115-x. Hear Res. 1999. PMID: 10511631

7

Transduction of the contralateral ear after adenovirus-mediated cochlear gene transfer.

Stöver T, Yagi M, Raphael Y. Stöver T, et al. Among authors: yagi m. Gene Ther. 2000 Mar;7(5):377-83. doi: 10.1038/sj.gt.3301108. Gene Ther. 2000. PMID: 10694819

8

Effect of transgenic GDNF expression on gentamicin-induced cochlear and vestibular toxicity.

Suzuki M, Yagi M, Brown JN, Miller AL, Miller JM, Raphael Y. Suzuki M, et al. Among authors: yagi m. Gene Ther. 2000 Jun;7(12):1046-54. doi: 10.1038/sj.gt.3301180. Gene Ther. 2000. PMID: 10871754

9

Spiral ganglion neurons are protected from degeneration by GDNF gene therapy.

Yagi M, Kanzaki S, Kawamoto K, Shin B, Shah PP, Magal E, Sheng J, Raphael Y. Yagi M, et al. J Assoc Res Otolaryngol. 2000 Dec;1(4):315-25. doi: 10.1007/s101620010011. J Assoc Res Otolaryngol. 2000. PMID: 11547811 Free PMC article.

10

Hair cell protection from aminoglycoside ototoxicity by adenovirus-mediated overexpression of glial cell line-derived neurotrophic factor.

Yagi M, Magal E, Sheng Z, Ang KA, Raphael Y. Yagi M, et al. Hum Gene Ther. 1999 Mar 20;10(5):813-23. doi: 10.1089/10430349950018562. Hum Gene Ther. 1999. PMID: 10210148

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,438 results

Search Page

Filters